Common side effects may include skin rashes, nausea, and abdominal pain
Functional assays, including CCK-8, colony formation, EdU incorporation, and Transwell migration assays, demonstrated that AFG3L2 loss significantly enhanced LUAD cell growth, proliferation, and migration (Fig
What this does not mean These findings do not mean that GLP-1 drugs should be used outside of a clinical trial to treat or prevent breast cancer
It is important to understand that GLP-3 medications are not the same as the FDA-approved weight loss medications currently available to qualifying patients
The FDA requires compounders to establish expiration dates conservatively, ensuring medication remains 90% potent or higher through the labeled shelf life
All medical services are provided by independently licensed healthcare providers through our partner provider network